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ABSTRACT 
 
 
Dual-component organic nanoparticles are prepared by a modified emulsion-templated 
freeze-drying approach to give an aqueous nanosuspensions showing Fluorescence (Förster) 
Resonance Energy Transfer (FRET) from within a distribution of single nanoparticles, 
dissolution of these particles results in loss of this FRET signal. Incubation of the particles 
with cells and analysis by confocal microscopy allows spatial and physical monitoring of the 
particles after internalization. 
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The formation of dual-component organic nanoparticles by a modified emulsion-templated 
freeze-drying approach has led to aqueous nanosuspensions showing Fluorescence (Förster) 
Resonance Energy Transfer (FRET) from within a distribution of single nanoparticles. The 
combination of both FRET dyes within dual-component nanoparticles (<200 nm) allows the 
spatial and physical monitoring of the particles as the FRET signal is lost on dissolution and 
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breakdown of the nanoparticles.  The monitoring of accumulation by Caco-2 cells and 
macrophages shows very limited internalization within the non-phagocytic cells. 
Conservation of FRET within the macrophages confirms extensive whole-particle 
internalization. The cellular permeability through Caco-2 monolayers was also assessed and 
movement of intact dual-component particles was observed, suggesting a mechanism for 
enhanced pharmacokinetics in vivo.  
 
1. Introduction 
The use of nanosuspensions, particles of pure drug in the sub-micron size range,
[1]
 has been 
heralded as an approach to address the issue of formulating poorly soluble active 
pharmaceutical ingredients (API)
[2-9]
 and has been successful in producing a range of new 
medicines, dosed daily in clinics globally.  These include the immunosuppressant 
Rapamune® (rapamycin), the chemotherapy-induced nausea prevention medicine Emend® 
(aprepitant) and the hypercholesterolemia treatment TriCor® (fenofibrate). The solid drug 
particles do not utilize a drug carrier or a drug vehicle, such as vesicles, micelles or 
pegylation,
[10]
 to overcome poor solubility, therefore each particle conveys high drug content, 
offering an efficient way to deliver drugs to, and/or into, cells. Additionally, formulating a 
poorly-soluble drug as a nanosuspension has been shown to enhance dissolution rate and 
improve bioavailability
[7, 11, 12]
 over conventional drug formulation approaches.  
The in vivo behavior of drugs in various nanoparticle forms has been subject to a 
considerable amount of research.
[13-15]
 Ongoing study continues to investigate the cellular 
uptake and accumulation of a wide range of nanoparticles, nanoparticulate drug delivery 
systems and colloidal particles with a specific emphasis on toxicity.
[14, 16]
 Nanosuspensions, 
typically composed of aggregates or crystals of poorly-soluble organic molecules, have a 
finite solubility and do not utilize a nanoscopic vehicle for delivery, therefore the 
nanoparticles will undergo continuous dissolution within the body.   
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The Caco-2 cell line, originating from human colorectal carcinoma, has been shown to 
spontaneously differentiate in culture to form a confluent monolayer with morphological and 
functional similarities to the small intestinal epithelium.
[17]
 As a result of these characteristics 
the Caco-2 monolayer has been developed as a model to study a range of therapeutic agents 
and delivery vehicles (microparticles,
[18]
 nanoparticles
[19]
 and nanocomplexes
[20]
). Hu and co-
workers compared the uptake into Caco-2 cells (human intestinal, non-phagocytic) and 
phagocytic cells (mouse macrophage RAW cells) of charcoal nanoparticles and a pyrene 
nanosuspension, using optical microscopy.
[21]
 Both types of particle displayed similar uptake 
behavior; limited in the Caco-2 cells but extensive in the RAW cells. The limitations of 
optical microscopy led to a lack of clarity regarding whether the pyrene particles were indeed 
internalized intact or transported as dissolved molecules with subsequent accumulation within 
the cell. Other studies have shown that nanosuspensions of hydrophobic drugs, produced by 
milling, gave an increase in the apparent permeability through a Caco-2 monolayer compared 
to un-milled drug. The authors suggested that improvement of oral bioavailability was due to 
increased dissolution rather than movement of particles through the cells of the 
gastrointestinal (GI) tract.
[2]
  The transport and fate of nanosuspensions within the body is 
therefore relatively poorly understood with respect to; a) whether particles, when orally 
dosed, cross the GI tract and enter the circulation intact, b) whether dissolution occurs before 
cellular uptake and c) whether particles remain intact over considerable timescales after 
uptake into phagocytic cells. Accurate monitoring of the physical state of nanosuspensions, 
and their dissolution, is therefore key to the study of cellular uptake. 
 Cellular uptake of block copolymer micelle drug delivery vehicles was investigated by 
Cheng and co-workers
[22]
 using Fluorescence (Förster) Resonance Energy Transfer 
(FRET).
[23]
 FRET relies upon non-radiative energy transfer (long-range, <10 nm, dipole-
dipole coupling) from a donor fluorophore in an electronic excited state, to a second 
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fluorophore, the acceptor. A FRET signal is observed when the donor molecule is excited and 
transfers its energy to the acceptor, resulting in acceptor emission. 
The micelles were loaded with a pair of FRET dyes (donor and acceptor) and were 
considered intact if a FRET signal was observed, indicating close proximity of the donor and 
acceptor fluorophores within the hydrophobic interior of the micelle. Decomposition of the 
micelles, or release of dye from the micelle, caused a loss in the FRET signal as the two 
fluorophore molecules became dissociated resulting in loss of energy transfer. We were 
interested in using the same concept to monitor the physical state of the particles during 
cellular uptake however, traditional top-down approaches used to produce nanosuspensions 
(such as milling or high-pressure homogenization) are not suitable for producing 
nanoparticles that contain two different organic molecules.  
In this paper we use a simple modified emulsion-templated freeze-drying method
[24]
 to 
produce a dual-component hydrophobic nanosuspension where particles contain a FRET 
fluorophore pair. We demonstrate that these particles indeed contain both fluorophores and 
that dissolution of the particles was accompanied by dramatic reduction in the FRET signal. 
These particles were used to investigate cellular uptake into human monocyte derived 
macrophages (activated THP-1 cells - A-THP-1) and Caco-2 cells before assessing the 
permeability of these particles through a Caco-2 cell monolayer. 
 
 
 
2. Results and Discussion 
2.1. Nanosuspension synthesis and characterization.  
Single component, containing one fluorophore, and dual-component, containing both 
acceptor and donor fluorophores, nanosuspensions were prepared by a modified emulsion-
templated freeze-drying method (Fig. 1). Briefly, 3,3'-dioctadecyloxacarbocyanine 
perchlorate (DiO) and 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate 
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(DiI) were dissolved in chloroform either individually or together in various ratios. The 
chloroform solutions were emulsified with an aqueous solution containing a non-ionic 
polyethylene oxide hexadecyl ether surfactant (Brij 58) and 80% hydrolyzed polyvinyl 
alcohol (PVA). After immediate freezing of the emulsions in liquid nitrogen the samples were 
lyophilized, removing the water and chloroform to yield a porous solid.  Addition of water to 
the products resulted in dissolution of the water-soluble polymer/surfactant matrix and release 
of the hydrophobic fluorophores as stabilized nanosuspensions. 
 
Analysis of the single component and dual-component dispersions by dynamic light 
scattering (DLS) showed mono-modal distributions with similar mean sizes (Fig. 2A). The z-
averages of the nanosuspensions were 184 nm, 123 nm and 165 nm (+/- 9 nm) with 
polydispersity indexes (defined in ISO13321) of 0.265, 0.255 and 0.228 (+/- 0.07) for single-
component DiO, single-component DiI and DiO50/DiI50 dual-component particles, 
respectively. Additionally, the nanosuspensions were stable for at least 1 month with average 
size and distribution remaining unchanged (supporting information (SI) Figure 1S). Zeta 
potential measurements of the nanosuspensions also indicated similar values which appeared 
to be largely independent of composition (10-12 mV (+/- 4 mV)), the minor cationic charge of 
the nanosuspensions arising from DiO and DiI. The low zeta potentials suggest that colloidal 
stability was given by the steric stabilization from adsorbed PVA and the overall similarity of 
the particles was considered appropriate for direct comparative studies. The nanoparticles 
were imaged using a graphene oxide (GO) support. Previous reports have demonstrated the 
advantages of using GO as a low contrast support for transmission electron microscopy 
(TEM)
[25-28]
 and recently as a support for multi-technique imaging by TEM, scanning electron 
microscopy (SEM) and atomic force microscopy (AFM).
[29]
 The three techniques can be 
performed concurrently on the same GO-grid, simplifying the collection of complementary 
images. Furthermore the nature of the GO grid allows for images to be collected unstained 
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and uncoated, minimizing misinterpretation of data and allowing for more accurate 
correlation of results. The morphology of the particles was first examined by TEM and SEM 
(Fig. 2B&C) and irregular, asymmetric shapes with a high aspect ratio were observed using 
both techniques. Characterization of the particles by AFM (Fig. 2D&E) yielded a similar 
morphology; flattened asymmetric particles in the same size range as determined by SEM and 
TEM. Although the sizes determined by TEM, SEM and AFM appear to be smaller than the 
DLS measurements, all values are consistent in showing the formation of <200 nm particles, 
especially when considering the approximation to spheres that is inherent in DLS 
measurement. Analysis of the materials by x-ray powder diffraction (XRPD) revealed that the 
particles were composed of the fluorophores in an amorphous state (SI Figure 2S).  
2.2 Characterizing nanosuspension fluorescence and FRET emission. FRET is a well 
established method used primarily to study protein interactions and conformation changes in 
situ.
[30]
 FRET occurs when two fluorophores with an overlap in their emission and excitation 
are within close proximity (less than 10 nm). FRET is observed as a decrease in the donor 
emission along with a concomitant increase in the emission of the acceptor occurring through 
the energy transfer from donor to acceptor. An unequivocal FRET signal therefore clearly 
demonstrates the presence of dual-component nanoparticles, i.e. single particles containing 
both fluorophores.  
DiO and DiI are a well reported FRET fluorophore pair and excitation of DiO at relatively 
low wavelengths will result in emission from DiI if the dyes are located within close 
proximity (Fig. 3E). In order to verify the occurrence of FRET, and therefore the co-
localisation of the two fluorophores within single combination particles, fluorescence spectra 
of both single and dual-component nanoparticles were obtained (Fig. 3). An excitation 
wavelength (ȜDiOex) of 420 nm was found to give good discrimination between DiO and DiI 
single-component nanosuspensions (SI Figure 5S); we found no effect on the emission peak 
wavelength when varying the excitation wavelength of any of the fluorescent 
   
88888888883888 
nanosuspensions, therefore no red-edge excitation shift 
[31, 32]
 was observed. The single-
component nanosuspension of DiO showed a peak emission (ȜDiOem) at 545 nm (Fig. 3A), 
while the single-component nanosuspension of DiI displayed a weak emission (ȜDiIem) at 598 
nm (Fig. 3B) due to poor excitation efficiency at 420 nm. Dual-component DiO50/DiI50 
nanosuspensions exhibited a single strong emission ȜDiIem peak (598 nm) when excited at 420 
nm (Fig. 3C) and no emission at 545 nm.  The absence of a ȜDiOem peak and the presence of a 
sole ȜDiIem peak when exciting the nanosuspension at ȜDiOex corresponds to efficient energy 
transfer between the two fluorophores. The extent to which FRET occurs may be quantified 
using the FRET ratio IDiI/(IDiO + IDiI), where IDiO and IDiI are the fluorescence intensities at 545 
and 598 nm respectively when exciting the nanosuspensions at ȜDiOex (420 nm). The 
DiO50/DiI50 dual-component nanosuspension displayed a FRET ratio of 0.98; almost complete 
energy transfer.  
The potential for the FRET behavior originating from the close proximity of separate 
particles of each fluorophore was studied by measuring the fluorescence of a 1:1 mixture of 
single component nanosuspensions of DiO and DiI (Fig. 3D). Two distinct emission peaks at 
540 and 598 nm were observed when the mixture was excited at 420 nm (FRET ratio of 0.30) 
indicating a low level of energy transfer occurring between the fluorophores when in separate 
particles and supporting the presence of DiO and DiI within the dual-component 
nanoparticles. 
The relative ratio of the donor to acceptor fluorophore within the dual-component particles 
was readily varied using the emulsion-templated freeze-drying nanoparticle synthesis. Dual-
component particles ranging in mean diameters between 120 – 255 nm were produced over a 
range of compositions from 100% DiO to 100% DiI. As the relative amount of DiO in the 
dual-component particles was increased, the average particle diameter in the dispersions was 
found also to generally increase (SI Figure 3S) at a constant PVA/Brij 58/total fluorophore 
ratio (weight %). Analysis of the fluorescence emission (Fig. 4A) of dual-component 
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nanosuspensions with varying DiO/DiI ratios showed that very low additions of acceptor (e.g. 
DiO90/DiI10) yielded a large increase in acceptor emission and subsequent decrease in donor 
emission (with a FRET ratio of 0.87). Further increases in the DiI content resulted in 
decreasing acceptor emission possibly due to increased self-quenching within the solid 
nanoparticles. Increasing the DiI content to DiO70/DiI30 yielded spectra with complete 
absence of the donor emission when the nanosuspensions were excited at ȜDiOex; thus all 
energy is transferred to the acceptor, DiI (a FRET ratio of 0.97). As a FRET ratio is defined as 
the acceptor emission divided by the sum of acceptor and donor emission, we have calculated 
FRET ratios across all compositions, understanding that a FRET ratio of a single-component 
nanosuspension of DiI will have a value very close to 1, similarly a single-component DiO 
nanosuspension has a value very close to zero. These values are clearly not derived from 
FRET however this approach allows comparison across the full composition range available. 
Varying the ratio of individual DiO particles to DiI particles in a mixture of the single-
component nanosuspensions led to completely different behavior (Fig 4B). Acceptor emission 
was not found to increase at any ratio of DiO/DiI, probably due to the isolation of donor and 
acceptor within individual particles. The potential for FRET is therefore restricted to either a) 
surface contact of the nanoparticles or b) energy transfer between the low concentrations of 
dissolved molecules of DiO and DiI (either in solution or within surfactant/polymer 
assemblies). The observed increase in FRET ratio (with increasing DiI content) is purely 
related to the subsequent reduction in DiO at increased DiI levels (to maintain constant total 
fluorophore concentration) and resulting decreased DiO emission.   
Particle breakdown or dissolution may also be observed by monitoring the FRET signal 
within the dual-component nanoparticles. As the particles begin to dissolve the two 
fluorophores are no longer co-localized within the particles and the distance between the 
donor and acceptor increases. For example, after dissolution of the DiO50/DiI50 dual-
component nanosuspension in methanol, FRET was found to be greatly reduced (Fig. 4C) 
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with the FRET ratio (the wavelengths chosen to represent the two fluorophores are adjusted to 
account for blue shift) reduced from 0.98 in water to 0.19 as a dissolved solution. 
Additionally, DLS analysis of the methanol solutions did not yield sufficient scattering for 
accurate size measurement, providing further evidence that particle dissolution had occurred. 
When a similar methanol dissolution was performed on a mixture (1:1) of DiO and DiI single-
component dispersions, nearly identical fluorescence spectra were observed, supporting our 
conclusions that the observed FRET signal from the single nanoparticle mixtures arises from 
low level energy transfer at the molecular or particle surface level. Blue shifting of the 
emission was observed for both DiO (-39 nm) and DiI (-28 nm) along with an increase in 
emission intensity upon dissolution. This finding was likely due to separation of fluorophores 
within the excimer assemblies present within the nanoparticles and a subsequent loss of self-
quenching.
[33]
 The dramatic reduction in FRET and FRET ratio during dual-component 
nanoparticle dissolution provides a useful measure allowing monitoring of the physical state 
of the nanosuspensions. 
 In order to verify that the dual-component nanosuspensions can be used at the appropriate 
concentrations for cellular uptake studies, serial dilution experiments were carried out using 
the DiO50/DiI50 dual-component nanosuspension to determine whether, at such low 
concentrations, nanoparticle dissolution would occur. (Fig. 4D). The FRET signal (acceptor 
emission from excitation at ȜDiOex) decreased in a linear manner as the nanosuspensions were 
diluted. The apparent decrease in the FRET ratio at very high dilutions was due to the very 
low acceptor emission relative to the noise in the measurement of the donor emission. The 
data suggest limited dual-component nanosuspension dissolution in the low concentration 
range required for cellular uptake and transport measurements using fluorescence 
spectroscopy. The dual-component nanoparticles are therefore useful probes for cellular 
uptake/transport experiments, allowing the combined spatial reporting and indication of 
physical state of the nanoparticles within the experiment.  
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2.3 Analysis of cellular uptake by confocal fluorescence microscopy. To investigate 
cellular uptake of the dual-component particles, A-THP-1 macrophages and Caco-2 intestinal 
cells were each incubated with dual-component nanosuspensions at 0.0125 mg/ml (14 ȝM 
fluorophore concentration) for 24 hours. Confocal fluorescence microscopy was utilized to 
visualize the cells during the 24 hour exposure (Fig. 5) and after 18 hours, dual-component 
particles had clearly been internalized by the A-THP-1 cells (Figure 5B). There was no visual 
evidence of aggregation of the nanosuspensions in the bulk media and separate DLS 
measurements of the nanosuspension in media confirmed no increase in particle size (SI 
Figure 6S). Although the mechanism of cellular uptake requires further investigation, a 
putative hypothesis is phagocytosis. Observation of Caco-2 cells showed very limited 
internalization of nanoparticles (SI Figure 8S) with the majority of particles adhered to the 
cell surface (Fig. 5E&F). While, cellular uptake of nanoparticles into Caco-2 cells has been 
shown in the literature,
[34-36]
 it also been reported to be highly dependent on a range of factors 
including size,
[34, 37]
 shape,
[37]
 hydrophilicity
[35]
 and composition.
[35]
 The low levels of uptake 
into Caco-2 cells, for the dual-component particles, was surprising however may be driven by 
a combination factors specific to our particles (eg the elongated shape and surface charge). 
The apparent differences in cellular uptake supports the hypothesis that the primary 
internalization mechanism is phagocytosis as Caco-2 cells are not phagocytic.
[21]
 
Full spectral analysis (lambda scan) of the emission of individual pixels within the confocal 
microscopy images allows quantification of the FRET ratio. This reports the physical state of 
the DiO50/DiI50 dual-component nanoparticles in the A-THP-1 cells (Fig. 6A&B). The 
emission spectra at a number of representative regions of interest (ROI) (up to 11 ROIs)  
inside the cells showed a clear difference between dual-component nanoparticles and the 
corresponding 1:1 mixture of DiO and DiI single-component nanoparticles (Fig. 6A&C). 
Very little donor emission, ȜDiOem, was observed for the DiO50/DiI50 dual-component 
nanoparticles indicating that the particles were internalized intact throughout the exposure. 
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However, the 1:1 mixture of DiO and DiI single-component nanoparticles displayed a clear 
donor emission (ȜDiOem) at 537 nm, slightly blue-shifted from the bulk measurements (Fig. 
3A) of 545 nm potential evidence of some dissolution of the DiO single-component 
nanoparticles. Interestingly, the mixture of DiO and DiI single-component nanoparticles also 
showed reduced donor emission inside the cell compared to the initial mixture of 
nanosuspensions (SI Figure 11S B). This indicates that the single-component donor and 
acceptor nanoparticles had been individually internalised and appear to accumulate within 
close proximity in the same regions of the cell. The FRET ratio (after 24 hours) was found to 
be significantly (with a p-value of 0.046) higher for the dual-component particles (0.89; Fig. 
6D) than for the mixture of single-component particles (0.74; Fig. 6E). pH studies of the dual-
component nanosuspensions in the absence of cells (SI Figure 12S), showed identical 
fluorescence spectra over a range of pH values (4.8-8.9). Investigation of the FRET ratios 
over the three time points showed that the FRET ratios remained constant over time for both 
dual-component (Fig. 6F) and the mixture of single-component nanoparticles (Fig. 6G), 
while the single-component particles seemed to display slightly greater accumulation. 
Comparison of the FRET ratios from within the cell (after 24 hours) against those of the 
aqueous dispersion (SI Figure 11S C) showed that the dual-component nanoparticles may 
have undergone slight particle dissolution as the FRET ratio decreased from 0.97 to 0.89. 
Overall, these findings provide strong evidence that the dual-component nanoparticles are 
internalized into A-THP-1 cells as intact structures with only minor dissolution.   
Transport of organic nanoparticles through Caco-2 cell monolayers was studied. This model 
has tight junctions and a luminal (apical) and systemic compartment (basolateral) mimicking 
the gut and blood, respectively.
[38]
 DiO50/DiI50 dual-component nanosuspensions were 
compared to a 1:1 mixture of DiO and DiI single-component nanosuspensions by addition to 
the apical compartment at a concentration relevant to in vivo drug particles dosed orally (50 
ȝM). After 18 hours the basolateral chamber (systemic circulation mimic) was sampled and 
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analyzed by fluorimetry (Fig. 7) to quantify the concentration of fluorophore that had 
transported through the monolayer. The low concentrations of fluorophore detected in the 
basolateral chamber indicated a low level of transport and required an excitation wavelength 
of 458 nm to increase overall emission from the samples. This wavelength provides less 
discrimination between FRET and DiI excitation/emission but this compromise was necessary 
to increase sensitivity and allow accurate fluorophore quantification.    
The emission spectra (Fig. 7A) of the basolateral compartment after 18 hours showed an 
observable fluorescence when applying either the dual-component or mixture of single-
component nanosuspensions to the apical compartment. Two specific peaks were observed in 
the spectra, one at approximately 505 nm, corresponding to DiO emission, and a second peak 
at approximately 575 nm assigned to DiI emission. In both cases, the dual-component and 
mixture of single-component nanosuspensions displayed blue shifted spectra (similar Ȝmax 
values as those observed in methanol) suggesting the presence of a majority of dissolved 
molecules after permeation. The emission spectra from the basolateral samples when using 
dual-component nanosuspensions displayed a noticeably stronger emission for both DiO and 
DiI (FRET ratio = 0.61) than samples taken when using a mixture of single-component 
nanosuspensions (FRET ratio = 0.52). The observed FRET ratio however provides no 
accurate quantification of the levels of fluorophore that has transported. To understand the 
physical nature of the nanosuspensions during transport it is important to quantify the 
acceptor fluorophore individually by using a second excitation wavelength of 550 nm (Fig. 
7B). The wavelength and emission intensity of DiI was approximately equal for both the dual-
component and the single-component nanosuspensions, implying that the same amount of DiI 
fluorophore had passed through the cell monolayer into the receiver well. The differences in 
FRET ratio (excitation at 458 nm) are therefore derived from the proximity of DiO and DiI in 
the basolateral chamber which suggests that at least some of the dual-component 
nanoparticles crossed the cell monolayer as intact particles; DiO and DiI permeating together 
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in a single nanoparticle. The observation of a FRET signal in the basolateral compartment, 
(Fig 7A) coupled with the low level of intracellular FRET signal in Caco-2 cells from our 
accumulation studies, (SI Figure 8S) would also indicate that the nanoparticles may have 
traversed the monolayer via a paracellular route, between the cells, rather than by permeation 
through the cell. Paracellular movement of nanoparticles has been shown previously,
[39]
 in the 
presence of chitosan either as particles or as dissolved molecules, enhancing drug transition 
through Caco-2 monolayers.
[40-42]
 It has been suggested that chitosan, carrying a permanent 
positive charge, causes reversible opening in the paracellular channels due to electrostatic 
interactions resulting in disruption of the tight junctions.
[42, 43]
 It is possible that the cationic 
character of our dual-component nanoparticles led to a similar disruption within the tight 
junctions. The potential for paracellular movement of the nanoparticles presented here is not 
completely intuitive, as our particles contain no chitosan. Further study, which may add 
considerable understanding to the enhanced bioavailability and pharmacokinetics observed for 
many nanosuspension medicines, is therefore required. 
 
3. Conclusions 
Unlike previous nanosuspension techniques, we have controllably generated a range of 
single-component and dual-component fluorescent nanoparticles (< 200nm) with varying 
composition using an emulsion-templated freeze-drying method.  By selecting a FRET-pair of 
fluorophores, we were able to determine the different fluorescence properties of mixtures of 
single component nanosuspensions and dual-component nanoparticles. The highly efficient 
FRET observed within the dual-component nanosuspensions allows the reporting of 
nanoparticle physical state using conventional fluorescence microscopy.  The application of 
the dual-component nanosuspensions to cellular uptake studies have demonstrated particle 
localization within, or at the surface, of the cells studied and the presence of intact particles 
within macrophages after only 4 hours incubation. Limited internalization of nanoparticles 
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was seen within Caco-2 cells but permeation experiments suggested the potential for 
paracellular transport of nanoparticles across an epithelial monolayer with tight junctions.  
The passage of intact nanoparticles across intestinal epithelial cells has implications that 
require further study as this may clarify mechanisms of modified in vivo behavior of current 
and potential nanoparticle therapies.          
 
 
3. Experimental  
Materials. Unless stated otherwise, all of the reagents and solvents were used as received. 
3,3'-dioctadecyloxacarbocyanine perchlorate (DiO) and 1,1'-dioctadecyl-3,3,3',3'-
tetramethylindocarbocyanine perchlorate (DiI) were purchased from Invitrogen. Poly(vinyl 
alcohol) (PVA; 80 % hydrolyzed, MW 9,000-10,000), Brij 58, RPMI-1640, phorbol 12-
myristate 13 acetate (PMA) and Dulbecco’s modified eagle’s medium were purchased from 
Sigma-Aldrich. 
Particle synthesis. Particles were prepared by emulsion templating followed by freezing and 
lyophilization. DiO or DiI were dissolved in chloroform at 10 mg/ml. 100 ȝl of DiO or DiI 
solution (or 50 ȝl of DiO and 50 ȝl DiI for the dual-component particles) was added to a 3 ml 
vial. To this organic solution 133 ȝl of Brij 58 (22.5 mg/ml in DI water) and 267 ȝl of PVA 
(80% hydrolyzed) (22.5 mg/ml in DI water) were added. An emulsion was formed by 
sonicating the sample for 12 seconds using a Covaris S2x with a duty cycle of 20, an intensity 
of 10 and 500 cycles/burst in frequency sweeping mode. The samples were then immediate 
frozen in liquid nitrogen. Lyophilizing for three days (Virtis benchtop K) yielded a porous 
solid that upon addition of water produced a nanosuspension.    
Particle characterization. The average size and zeta potential of the nanosuspensions were 
measured at 1 mg/ml at a temperature of 25˚C using a Malvern Zetasizer Nano ZS equipped 
with a 4mW He-Ne, 633nm laser. The z-average diameters and polydispersity indexes were 
obtained by DLS. Malvern Zetasizer software version 6.20 was used for data analysis. Zeta 
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potential measurements were also carried out at 1 mg/ml, at 25˚C, a pH of 6.5, using 
disposable capillary zeta cells. The fluorescence spectra of the nanoparticle dispersion were 
obtained on a PerkinElmer LS55 using disposable UV-grade PMMA cuvettes with a path 
length of 1 cm. For fluorescence spectrometry the emulsion-templated solids were dispersed 
in deionised water to a fluorophore concentration of 0.032 mg/ml. For the dissolution in 
methanol experiments the solids were first dispersed in water at 1 mg/ml which was then 
dissolved in methanol to a concentration of 0.016 mg/ml. The excitation and emission slits 
were unchanged when measuring spectra that were directly compared and no normalization of 
the data was carried out.  
Electron microscopy. Prior to electron microscopy the dual-component sample 
(DiO50/DiI50) was dialyzed for 4 days using a biodialyzer fitted with cellulose acetate 
membranes with a molecular weight cut-off of 50,000 daltons (Harvard Apparatus) (dialysis 
was found to have no effect on particle size (SI Figure 4S)). All electron microscopy images 
were obtained with the sample deposited on a modified TEM grid, these were prepared as 
follows: Solutions of graphene oxide
[28]
 were synthesized as previously reported. GO 
solutions (0.10 - 0.15 mg/ml) were sonicated for 30 seconds prior to use. Lacey carbon grids 
(400 Mesh, Cu) (Agar Scientific) were cleaned using air plasma from a glow-discharge 
system (2 min, 20 mA). One drop (~ 0.08 ml) of the sonicated GO solution was deposited 
onto each grid and left to air-dry for ~ 30 min. 4 µL of sample (at 0.5 mg/ml) was pipetted 
onto a GO grid and blotted immediately blotted away using a piece of filter paper. TEM 
images were recorded on either a JEOL 2000FX TEM or a JEOL 2100 equipped with Gatan 
Orius digital camera, both were operated at 200kV. While, a Zeiss Supra55VP was used to 
acquire the SEM images, operated at an accelerating voltage of 20 kV. 
Atomic force microscopy (AFM). AFM images were taken in tapping mode on a Multimode 
AFM with Nanoscope IIIA controller with Quadrex. Silicon AFM tips were used with 
nominal spring constant and resonance frequency of 3.5 Nm
-1
 and 75 kHz (MikroMasch 
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NSC18). ImageJ 1.44 with the interactive 3D surface plot plugin was used to produce the 
AFM surface plot. 
Routine Cell culture. Caco-2 cells were purchased from American Type Tissue Culture 
(ATCC: USA) and THP-1 cells were purchased from European Collection of Cell Cultures 
(ECCAC; Porton Down, UK). Caco-2 cells were routinely maintained in Dulbecco’s modified 
eagle’s medium (DMEM) supplemented with 15% fetal bovine serum (FBS; BioWhittaker, 
Berkshire, UK) and THP-1 cells were grown in RPMI-1640 supplemented with 10% FBS. 
Both cell lines were incubated at 37°C and 5% CO2 and Caco-2 cells were sub-cultured every 
4 days. THP-1 cells were sub-cultured when a density of 1 x 10
6 
cells/ml was achieved, prior 
to being seeded at a density of 2.5 x 10
4
/ml into 12 wells of an Iwaki 24 well glass bottomed 
plate (Asahi Glass Co; Japan). Activation of THP-1 cells into macrophage-like cells (A-THP-
1) was accomplished by addition of phorbol 12-myristate 13 acetate (PMA; 10nM) and 
incubation at 37°C and 5% CO2 for 7 days. Caco-2 cells were seeded at a density of 2.5 x 
10
4
/ml into the remaining 12 wells of an Iwaki 24 well glass bottomed plate and allowed 
24 hours to adhere. 
Confocal microscopy. The emulsion-templated solids were dispersed in deionised water to a 
fluorophore concentration of 1.0 mg/ml. These dispersions were then diluted with the 
appropriate cell specific media (i.e. RPMI-1640 and 10% FBS for A-THP-1 or DMEM 
supplemented with 10% FBS for Caco-2) to 0.0125 mg/ml (14 ȝM fluorophore 
concentration). A-THP-1 cells were then incubated with either dual-component particles with 
a DiO:DiI ratio of 1:1, whereas Caco-2 cells were incubated with dual-component particles 
with a DiO:DiI ratio of 7:3. Images were obtained by confocal laser scanning microscopy at 4, 
18 and 24 hours after addition of the nanosuspensions. A Zeiss LSM510 or a Zeiss LSM710 
on a Zeiss Observer Z1 (Zeiss, Jena, Germany) were used for imaging. The nanosuspensions 
were excited using an argon ion laser at 458 nm and detected with a Zeiss Meta detector. In 
the confocal channel images (Figure 5) a spectral filter of 570-673 nm was used FRET 
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emission. For the spectral analysis the emission between 500-700 nm was collected at 10 nm 
intervals. Data was captured using Zeiss Zen software (Zeiss, Jena, Germany) and analyzed 
using Zeiss LSM image browser (version 4,2,0,121). 
Transwell experiment. Caco-2 cells were inoculated (4 x 10
4
 cells per well) onto Corning 24 
Well HTS Transwell support plates (Corning Ltd) and allowed to propagate, differentiate and 
polarize over a 21 day period as previously described,
[38]
 where the cell media (DMEM 
containing 15% FBS) was replaced every other day. The emulsion-templated solids were 
dispersed in deionised water to a fluorophore concentration of 1.0 mg/ml. These 
nanosuspensions were then diluted to 50 ȝM in Hanks buffer containing 0.5mM L-glutamine. 
These nanosuspensions were added to the apical compartment (intestinal lumen mimic) and 
transcellular permeability was assessed by fluorimetry (PerkinElmer LS55) after pooling the 
recipient buffer contained in 5 basolateral compartments after 18 hours incubation.  
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FIGURE 1 
 
 
 
 
 
 
 
FIGURE 1 CAPTION 
 
Figure 1. Schematic representation of single and dual-component fluorescent nanosuspension 
production. Fluorophores were dissolved in chloroform and emulsified in an aqueous solution 
containing surfactant and a polymer stabilizer. The emulsions were then cryogenically frozen 
and lyophilized to yield an emulsion-templated porous solid. Upon dispersion into water, the 
porous solids form nanosuspensions of solid fluorescent nanoparticles. A) Production of a 
DiO single-component nanosuspension; B) Production of a DiI single-component 
nanosuspension; C) Production of a DiO and DiI dual-component nanosuspension. 
 
  
 
 
 
 
 
   
222222222222222222223222222 
 
 
 
 
FIGURE 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2 CAPTION 
 
 
Figure 2. Physical characterization of fluorescent nanoparticles. A) Dynamic light scattering 
analysis (intensity weighted size distribution) of the three nanosuspensions (at nanoparticle 
concentrations of 1 mg/ml); DiO single-component (orange), DiI single-component (purple) 
and DiO50/DiI50 dual-component (red); B) SEM micrograph of the DiO50/DiI50 dual-
component particles; C) TEM micrograph of DiO50/DiI50 dual-component particles; D) AFM 
image of a single DiO50/DiI50 dual-component particle; E) Surface plot of the particle in the 
AFM image.  
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FIGURE 3 
 
 
 
 
  
 
 
 
FIGURE 3 CAPTION 
 
Figure 3. Fluorescence emission spectra of different nanosuspensions obtained upon 
excitation at 420 nm (at an overall nanoparticle concentration of 0.032 mg/ml). A) DiO 
single-component nanosuspension (yellow); B) DiI single-component nanosuspension 
(purple); C) DiO50/DiI50 dual-component nanosuspension (red; FRET ratio = 0.98); D) 1:1 
mixture of both single-component DiO and single-component DiI nanosuspensions (0.016 
mg/ml of DiO nanosuspension and 0.016 mg/ml of DiI nanosuspension (total fluorophore 
concentration 0.032 mg/ml)) (Black dotted line; FRET ratio 0.30); E) A scheme for the FRET 
signal from the dual-component nanoparticles.   
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FIGURE 4 
 
 
 
 
 
FIGURE 4 CAPTION 
 
 
Figure 4. Fluorescence characterization of single and dual-component nanosuspensions upon 
excitation at ȜDiOex (420 nm): A) Effect of varying the ratio of DiO to DiI on fluorescent 
emission of dual-component nanosuspension (nanoparticle concentration of 0.032 mg/ml); B) 
Effect of varying the ratio of DiO to DiI on fluorescent emission of a mixture of single-
component nanosuspensions of DiO and DiI (total nanoparticle concentration of 0.032 
mg/ml); C) Fluorescent emission spectra of DiO50/DiI50 dual-component nanosuspensions in 
water (red line; FRET ratio 0.98), DiO50/DiI50 dual-component nanosuspensions in methanol 
(green line; FRET ratio 0.17), a 1:1 mixture DiO and DiI single-component nanosuspensions 
in water (black dotted line; FRET ratio 0.30) or a 1:1 mixture DiO and DiI single-component 
nanosuspensions in methanol (purple dotted; line; FRET ratio 0.19). The total fluorophore 
concentrations were 0.016 mg/ml for all four spectra. D: Effect of dilution on the fluorescent 
emission of the DiO50/DiI50 dual-component nanosuspension.  
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FIGURE 5 
 
 
 
 
 
 
FIGURE 5 CAPTION 
 
Figure 5. Confocal fluorescence microscopy of A-THP-1 and Caco-2 cells exposed to dual-
component nanosuspensions (14 ȝM fluorophore concentration) at three different incubation 
times. FRET emission from the dual-component nanosuspensions is represented in yellow. 
(Scale bars are 40 ȝm). 
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FIGURE 6 
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FIGURE 6 CAPTION 
 
 
 
Figure 6. Confocal fluorescence microscopy analysis of A-THP-1 cells incubated with either 
a dual-component nanosuspension (DiO50/DiI50) or a 1:1 mixture of single-component 
nanosuspensions (14 ȝM fluorophore concentration) (corresponding brightfield images SI 
Figure 11S): A) Confocal lambda scan of A-THP-1 cells incubated with a dual-component 
nanosuspension (upper) or a mixture of single-component nanosuspensions (lower) (the scale 
bars are 20 ȝm); B&C) Spectral analysis of five ROIs within cells (all the ROIs selected are 
shown in SI Figure 8S) - arrows indicate ȜDiOem (537 nm);  Individual ROI FRET ratios for D) 
accumulated dual-component nanoparticles (blue line shows average across ROIs) and E) 
accumulated mixture of single-component nanoparticles (red line shows average across 
ROIs); Monitoring of fluorescence of accumulated nanoparticles during incubation of cells 
with F) dual-component nanosuspension and G) mixture of single-component 
nanosuspensions - emission intensities of the donor (537 nm) and acceptor (595 nm) and 
FRET ratios are shown as the mean from the ROIs.  
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FIGURE 7 
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Figure 7. Fluorescent emission spectra of DiO50/DiI50 dual-component nanosuspensions and 
the 1:1 mixture of DiO single-component and DiI single-component nanosuspensions after 
transport through Caco-2 cell monolayer (incubated at 50 ȝM fluorophore concentration); A) 
Emission spectra of nanosuspensions with an excitation wavelength of 458 nm (ȜDiOex); B) 
Emission spectra of nanosuspensions with an excitation wavelength of 550 nm (ȜDiIex).   
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Figure 1S. Stability of the dual-component (DiO50/DiI50) nanosuspension when dispersed in 
water at 1 mg/ml. 
 
 
Figure 2S. Powder x-ray diffraction (PXRD) of single and dual-component freeze-dried 
monoliths (DiO50/DiI50) along with the starting materials used to produce the monoliths. 
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Figure 3S. DLS analysis of the effect of varying the ratio of DiO to DiI in (A) dual-
component particles or (B) a mixture of single-component particles of DiO and DiI 
(nanoparticle concentration of 1 mg/ml). 
 
 
Figure 4S. Effect of 4 days dialysis on the particle size distribution of dual-component 
(DiO50/DiI50) nanosuspension. Before dialysis the particles had a z-average diameter of 186 
nm and afterward the z-average diameter was 181 nm. Samples were analyzed by DLS at a 
nanoparticle concentration of 0.5 mg/ml.   
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Figure 5S. Absorption (top) and excitation (bottom) spectra for single and dual-component 
nanosuspensions (DiO50/DiI50). The absorption measurement were obtained at a particle 
concentration of 0.5 mg/ml (using a Thermo Scientific Nanodrop 2000c in pedestal mode).  
For the excitation spectra measurements the nanosuspensions were at 0.032 mg/ml and the 
emission wavelength was set to 550 nm for the DiO nanosuspension and 600 nm for the DiI 
or dual-component nanosuspensions.  
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Figure 6S. Effect of cell media (RPMI-1640 supplemented with 10% FBS) on particle size as 
measured DLS. The z-average diameters were 25 nm, 159 nm and 138 nm for the media, 
dual-component (DiO50/DiI50) nanosuspension (nanoparticle concentration 0.1 mg/ml) and 
media containing dual-component (DiO50/DiI50) nanosuspension (nanoparticle concentration 
0.1 mg/ml).     
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Figure 7S. Orthogonal section of a confocal image of an ATHP-1 cell after 24 hours 
incubation with dual-component nanosuspension in which the focal plane is in the interior of 
the cells. 
 
Figure 8S. Orthogonal section of a confocal image of a Caco-2 cell after 19 hours incubation 
with dual-component nanosuspension in which the focal plane is in the interior of the cells. 
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Figure 9S. Confocal microscopy of the A-THP-1 cells incubated with DiO50/DiI50 dual-
component nanosuspension or a 1:1 mixture of single-component DiO and single-component 
DiI nanosuspensions. The ROIs selected for spectral analysis for all time points are shown. 
 
Figure 10S. Brightfield images corresponding to the images obtained by confocal 
fluorescence microscopy. 
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Figure 11S. Comparison of fluorescence emission of dual-component (DiO50/DiI50) and a 
mixture of single-component nanoparticles accumulated within the A-THP-1 cells to a free 
nanosuspension. A: Comparison of the dual-component nanosuspension emission spectra for 
the nanoparticles accumulated within the A-THP-1 cells to the free nanosuspension. B: 
Comparison of the mixture of single-component nanosuspensions emission spectra for the 
nanoparticles accumulated within the A-THP-1 cells to the free nanosuspension. C: The 
FRET ratios for either the dual-component nanoparticles or mixture of single-component 
nanoparticles, accumulated within the inside of the cells and as the free nanosuspension.  
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Figure 12S. The effect of pH on the dual-component (DiO50/DiI50) nanosuspensions. A: DLS 
analysis of the nanosuspension at three different pHs (particles at 0.1 mg/ml). The z-averages 
were 151 nm, 159 nm and 159 nm at the pHs of 4.8, 6.2 and 8.8 respectively. B: Fluorescent 
emission of the dual-component particles at three different pHs using an excitation 
wavelength of 420 nm (particles at 0.0125 mg/ml). The FRET ratios at the three pH values 
were 0.97, 0.98 and 0.97 for pH 4.8, 6.2 and 8.8 respectively (FRET ratio was calculated as 
Ȝ595 /Ȝ537 + Ȝ595).  
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Figure 13S. Photograph of the fluorescence nanosuspensions. Left to right: The DiO single-
component nanosuspension, DiI single-component nanosuspension and the DiO50/DiI50 dual-
component nanosuspension. All nanosuspensions were at 1 mg/ml. 
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